Michael K. Wendt
Associate Professor | Internal Medicine |
OFFICE
Medical Education Research Facility Rm 2206 Iowa City, IA 52242 AREAS OF RESEARCH Molecular Biology Cancer Biology Models of Metastasis Genetics Pharmacology |
LAB
Medical Education Research Facility Rm 2234 Iowa City, IA 52242 EDUCATION B.S., Biology, St. Norbert College, DePere, WI Ph.D., Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI |
BIOGRAPHY
Dr. Wendt graduated with a bachelor's degree from St. Norbert College in 2002. After completing his graduate studies at the Medical College of Wisconsin in 2008, Dr. Wendt became an American Cancer Society fellow with Dr. William Schiemann at the University of Colorado Cancer Center. In 2010 Dr. Wendt moved with the Schiemann lab to Case Western Reserve University where he received a K99/R00 transition award from the NCI. Dr. Wendt joined the faculty of Purdue University as an Assistant Professor in 2014. In 2016 Dr. Wendt was awarded the the Research Scholar Grant for the American Cancer Society. In 2019 Dr. Wendt was promoted to Associate Professor with tenure. From 2020-2024 Dr. Wendt was a standing member of the tumor evolution, heterogeneity, and metastasis (TEHM) study section for the NIH. In 2022 Dr. Wendt become a Showalter faculty scholar in life sciences at Purdue University. In 2023 Dr. Wendt was recruited to the Holden Comprehensive Cancer Center at the University Iowa where he is the Arlene Holden Professor of Breast Cancer Research and the program leader of Experimental Therapeutics for Holden Comprehensive Cancer Center.
Dr. Wendt graduated with a bachelor's degree from St. Norbert College in 2002. After completing his graduate studies at the Medical College of Wisconsin in 2008, Dr. Wendt became an American Cancer Society fellow with Dr. William Schiemann at the University of Colorado Cancer Center. In 2010 Dr. Wendt moved with the Schiemann lab to Case Western Reserve University where he received a K99/R00 transition award from the NCI. Dr. Wendt joined the faculty of Purdue University as an Assistant Professor in 2014. In 2016 Dr. Wendt was awarded the the Research Scholar Grant for the American Cancer Society. In 2019 Dr. Wendt was promoted to Associate Professor with tenure. From 2020-2024 Dr. Wendt was a standing member of the tumor evolution, heterogeneity, and metastasis (TEHM) study section for the NIH. In 2022 Dr. Wendt become a Showalter faculty scholar in life sciences at Purdue University. In 2023 Dr. Wendt was recruited to the Holden Comprehensive Cancer Center at the University Iowa where he is the Arlene Holden Professor of Breast Cancer Research and the program leader of Experimental Therapeutics for Holden Comprehensive Cancer Center.